Association between serum ghrelin concentrations and depression severity in patients with irritable bowel syndrome: a clinic-based case–control study

Irritable bowel syndrome (IBS) is a functional gastrointestinal disease commonly associated with psychological comorbidities. Ghrelin, a gut-derived peptide hormone participated in gut-brain axis regulation, may play a role in both gastrointestinal and emotional symptoms. This study aimed to investigate the association between ghrelin levels in serum and depression severity in a Northwestern Iranian patients with IBS. In this case–control study, 140 IBS patients (diagnosed based on Rome III criteria) and 115 age- and sex-matched healthy controls were enrolled. Depression severity was assessed using the Beck Depression Inventory-II (BDI-II). Also, serum ghrelin concentrations were measured via an enzyme-linked immune-sorbent assay (ELISA). Statistical analyses included independent t-test, ANOVA, linear regression, and Pearson’s correlation analysis. Our results showed that IBS patients had significantly lower ghrelin levels compared to healthy controls ( P = 0.001). IBS patients with minimal, mild, moderate, or severe depressive symptoms (≥ 29) exhibited lower ghrelin levels than controls with mild depression (All, P = 0.00). Serum ghrelin levels were inversely correlated with IBS severity ( r = − 0.18, P = 0.001). Also, serum ghrelin remained a significant predictor of BDI-II score (standardized β = −0.442, P < 0.001). In multivariable analysis, serum ghrelin remained independently associated with depression severity after adjustment for age, sex, and BMI ( P < 0.001). Decreased ghrelin levels in IBS patients are linked to higher depression severity and this issue is the major driver of disease severity. These findings suggest a potential role of the gut–brain axis in the IBS and psychological symptoms interactions. However, further research is needed to clarify the underlying mechanisms since causal relationships cannot be inferred based on the cross-sectional study.

Authors

Institutions

Publication Details

Journal
BMC Gastroenterology
Published
2026-11-10
DOI
https://doi.org/10.1186/s12876-026-05526-6
Primary Topic
Gastrointestinal motility and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association between serum ghrelin concentrations and depression severity in patients with irritable bowel syndrome: a clinic-based case–control study

Farhad Pourfarzi, Somaieh Matin, Masoomeh Dadkhah
BMC Gastroenterology
Gastrointestinal motility and disorders
article

Association between serum ghrelin concentrations and depression severity in patients with irritable bowel syndrome: a clinic-based case–control study

Farhad Pourfarzi, Somaieh Matin, Masoomeh Dadkhah
article en

Abstract

Irritable bowel syndrome (IBS) is a functional gastrointestinal disease commonly associated with psychological comorbidities. Ghrelin, a gut-derived peptide hormone participated in gut-brain axis regulation, may play a role in both gastrointestinal and emotional symptoms. This study aimed to investigate the association between ghrelin levels in serum and depression severity in a Northwestern Iranian patients with IBS. In this case–control study, 140 IBS patients (diagnosed based on Rome III criteria) and 115 age- and sex-matched healthy controls were enrolled. Depression severity was assessed using the Beck Depression Inventory-II (BDI-II). Also, serum ghrelin concentrations were measured via an enzyme-linked immune-sorbent assay (ELISA). Statistical analyses included independent t-test, ANOVA, linear regression, and Pearson’s correlation analysis. Our results showed that IBS patients had significantly lower ghrelin levels compared to healthy controls ( P = 0.001). IBS patients with minimal, mild, moderate, or severe depressive symptoms (≥ 29) exhibited lower ghrelin levels than controls with mild depression (All, P = 0.00). Serum ghrelin levels were inversely correlated with IBS severity ( r = − 0.18, P = 0.001). Also, serum ghrelin remained a significant predictor of BDI-II score (standardized β = −0.442, P < 0.001). In multivariable analysis, serum ghrelin remained independently associated with depression severity after adjustment for age, sex, and BMI ( P < 0.001). Decreased ghrelin levels in IBS patients are linked to higher depression severity and this issue is the major driver of disease severity. These findings suggest a potential role of the gut–brain axis in the IBS and psychological symptoms interactions. However, further research is needed to clarify the underlying mechanisms since causal relationships cannot be inferred based on the cross-sectional study.

BMC Gastroenterology
Ardabil University of Medical Sciences (IR)
Gastrointestinal motility and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon